TEVA PHARMACEUTICAL INDUSTRIES LIMITED Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) had Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value of $689.00 million as of 2018-03-31, per its 10-Q filed 2018-05-03.
Discontinued › Notes › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue · last filed 2018-05-03
- 2018-03-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value $689.00M.
- 2017-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value $717.00M; Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value as first filed -$717.00M.
- 2017-09-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value -$790.00M.
- 2017-06-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value -$900.00M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value as first filed |
|---|---|---|
| 2018-03-31 | $689.00M 10-Q · filed 2018-05-03 | |
| 2017-12-31 | $717.00M 10-Q · filed 2018-05-03 | -$717.00M 10-K · filed 2018-02-12 |
| 2017-09-30 | -$790.00M 6-K · filed 2017-11-02 | |
| 2017-06-30 | -$900.00M 6-K · filed 2017-08-03 | |
| 2017-03-31 | -$822.00M 6-K · filed 2017-05-11 | |
| 2016-12-31 | -$811.00M 10-K · filed 2018-02-12 | |
| 2016-09-30 | -$614.00M 6-K · filed 2016-11-15 | |
| 2016-06-30 | -$661.00M 6-K · filed 2016-08-04 | |
| 2016-03-31 | -$823.00M 6-K · filed 2016-05-09 | |
| 2015-12-31 | -$811.00M 6-K · filed 2017-11-02 | |
| 2015-09-30 | -$772.00M 6-K · filed 2015-10-29 | |
| 2015-06-30 | -$705.00M 6-K · filed 2015-07-30 | |
| 2015-03-31 | -$900.00M 6-K · filed 2015-04-30 | |
| 2014-12-31 | -$616.00M 20-F · filed 2017-02-15 | |
| 2014-09-30 | -$608.00M 6-K · filed 2014-10-30 | |
| 2014-06-30 | -$373.00M 6-K · filed 2014-07-31 | |
| 2014-03-31 | -$368.00M 6-K · filed 2014-05-02 | |
| 2013-12-31 | -$347.00M 6-K · filed 2015-10-29 | |
| 2013-09-30 | -$348.00M 6-K · filed 2013-10-31 | |
| 2013-06-30 | -$127.00M 6-K · filed 2013-08-01 | |
| 2013-03-31 | -$105.00M 6-K · filed 2013-05-02 | |
| 2012-12-31 | -$98.00M 20-F · filed 2015-02-09 | |
| 2012-09-30 | -$88.00M 6-K · filed 2012-11-01 | |
| 2012-06-30 | -$147.00M 6-K · filed 2012-08-02 | |
| 2012-03-31 | -$142.00M 6-K · filed 2012-05-09 | |
| 2011-12-31 | -$139.00M 20-F · filed 2014-02-10 | $203.00M 20-F · filed 2012-02-17 |
| 2011-09-30 | $41.00M 6-K · filed 2011-11-02 | |
| 2011-06-30 | $42.00M 6-K · filed 2011-07-28 | |
| 2011-03-31 | $56.00M 6-K · filed 2011-05-11 | |
| 2010-12-31 | $78.00M 20-F · filed 2013-02-12 | |
| 2010-09-30 | $69.00M 6-K · filed 2010-11-02 | |
| 2010-06-30 | $69.00M 6-K · filed 2010-07-27 | |
| 2009-12-31 | $76.00M 20-F · filed 2012-02-17 | |
| 2009-09-30 | $65.00M 6-K · filed 2010-11-02 | |
| 2009-06-30 | $75.00M 6-K · filed 2010-07-27 | |
| 2008-12-31 | $98.00M 20-F · filed 2011-02-15 |